Korean Journal of Biological Psychiatry (생물정신의학)

The Korean Society of Biological Psychiatry (대한생물정신의학회)
권호 표지

At Risk State for Psychosis : Related Issues and Future Directions

정신병 위험상태 : 관련된 문제와 향후 전망

  • Roh, Dae-Young (Department of Psychiatry, Yonsei University College of Medicine) ;
  • Kim, Chan-Hyung (Department of Psychiatry, Yonsei University College of Medicine)
  • 노대영 (연세대학교 의과대학 정신과학교실) ;
  • 김찬형 (연세대학교 의과대학 정신과학교실)
  • Received : 2011.08.11
  • Accepted : 2011.09.30
  • Published : 2011.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

In medicine, general clinical practice moves in the direction of early detection and intervention for the prevention of progressive disease. In psychiatry, research in subjects with the risk syndrome for psychosis, has been conducted for the prevention of schizophrenia, known as a devastating chronic disease. The inclusion of 'attenuated psychosis syndrome', based on the results of early intervention studies, is one of the major issues in the upcoming DSM-V. Further investigations are needed to find biological markers and endophenotypes to supplement the diagnostic criteria. In the future, adoption of clinical staging is promising to overcome the shortcoming of current diagnosis of schizophrenia. In clinical practice, more concerns are needed about attenuated psychotic symptoms which might be risk signals for the transition to psychosis.

Keywords

References

  1. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 1994;151:1409-1416.
  2. McGorry PD. Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 2007;164:859-860. https://doi.org/10.1176/appi.ajp.164.6.859
  3. Arango C. Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry. Eur Child Adolesc Psychiatry 2011;20:67-70.
  4. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 2006;40:616-622. https://doi.org/10.1080/j.1440-1614.2006.01860.x
  5. McGorry PD, Mihalopoulos C, Henry L, Dakis J, Jackson HJ, Flaum M, et al. Spurious precision: procedural validity of diagnostic assessment in psychotic disorders. Am J Psychiatry 1995;152:220-223.
  6. Carpenter WT. Anticipating DSM-V: should psychosis risk become a diagnostic class? Schizophr Bull 2009;35:841-843. https://doi.org/10.1093/schbul/sbp071
  7. Pincus HA, McQueen LE, Elinson L. Subthreshold mental disorders: Nosological and research recommendations. Advancing DSM: Dilemmas in Psychiatric Diagnosis Washington DC: American Psychiatric Association;2003. p.129-144.
  8. Meares A. The diagnosis of prepsychotic schizophrenia. Lancet 1959; 1:55-58.
  9. Olin SC, Mednick SA, Cannon T, Jacobsen B, Parnas J, Schulsinger F, et al. School teacher ratings predictive of psychiatric outcome 25 years later. Br J Psychiatry Suppl 1998;172:7-13. https://doi.org/10.1192/bjp.172.1.7
  10. Hafner H, an der Heiden W. The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies. Eur Arch Psychiatry Clin Neurosci 1999;249 Suppl 4:14-26.
  11. Hafner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Löffler W, et al. Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull 1998;24:99-113. https://doi.org/10.1093/oxfordjournals.schbul.a033317
  12. Verdoux H, Cougnard A. Schizophrenia: who is at risk? Who is a case? Int Clin Psychopharmacol 2006;21 Suppl 2:S17-S19.
  13. Drake RJ, Lewis SW. Early detection of schizophrenia. Curr Opin Psychiatry 2005;18:147-150. https://doi.org/10.1097/00001504-200503000-00007
  14. Corcoran CM, First MB, Cornblatt B. The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis. Schizophr Res 2010;120:16-22. https://doi.org/10.1016/j.schres.2010.03.018
  15. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl 1998;172:14-20.
  16. Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry 1996;30:587-599. https://doi.org/10.3109/00048679609062654
  17. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005;39:964- 971. https://doi.org/10.1080/j.1440-1614.2005.01714.x
  18. Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q 1999;70:273-287. https://doi.org/10.1023/A:1022034115078
  19. Gross G. The 'basic' symptoms of schizophrenia. Br J Psychiatry Suppl 1989:21-25; discussion 37-40.
  20. Schultze-Lutter F, Klosterkotter J, Picker H, Steinmeyer EM, Ruhrmann S. Predicting first-episode psychosis by basic symptom criteria. Clin Neuropsychiatry 2007;4:11-22.
  21. Yung AR, Nelson B, Thompson AD, Wood SJ. Should a "Risk Syndrome for Psychosis" be included in the DSMV? Schizophr Res 2010; 120:7-15. https://doi.org/10.1016/j.schres.2010.03.017
  22. Woods SW, Walsh BC, Saksa JR, McGlashan TH. The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res 2010;123:199-207. https://doi.org/10.1016/j.schres.2010.08.012
  23. Wong C, Davidson L, Anglin D, Link B, Gerson R, Malaspina D, et al. Stigma in families of individuals in early stages of psychotic illness: family stigma and early psychosis. Early Interv Psychiatry 2009;3:108-115. https://doi.org/10.1111/j.1751-7893.2009.00116.x
  24. Cosgrove L, Bursztajn HJ, Krimsky S. Developing unbiased diagnostic and treatment guidelines in psychiatry. N Engl J Med 2009;360: 2035-2036. https://doi.org/10.1056/NEJMc0810237
  25. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008;65:28-37. https://doi.org/10.1001/archgenpsychiatry.2007.3
  26. Niendam TA, Jalbrzikowski M, Bearden CE. Exploring predictors of outcome in the psychosis prodrome: implications for early identification and intervention. Neuropsychol Rev 2009;19:280-293. https://doi.org/10.1007/s11065-009-9108-z
  27. Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 2001; 31:381-400.
  28. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005;62:975-983. https://doi.org/10.1001/archpsyc.62.9.975
  29. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005; 162:1785-1804. https://doi.org/10.1176/appi.ajp.162.10.1785
  30. Walterfang M, Yung A, Wood AG, Reutens DC, Phillips L, Wood SJ, et al. Corpus callosum shape alterations in individuals prior to the onset of psychosis. Schizophr Res 2008;103:1-10. https://doi.org/10.1016/j.schres.2008.04.042
  31. Takahashi T, Wood SJ, Yung AR, Soulsby B, McGorry PD, Suzuki M, et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry 2009;66: 366-376. https://doi.org/10.1001/archgenpsychiatry.2009.12
  32. Lappin JM, Dazzan P, Morgan K, Morgan C, Chitnis X, Suckling J, et al. Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis. Br J Psychiatry Suppl 2007;51: s123-s127.
  33. Zipparo L, Whitford TJ, Redoblado Hodge MA, Lucas S, Farrow TF, Brennan J, et al. Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:531-538. https://doi.org/10.1016/j.pnpbp.2007.10.011
  34. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009;35:894-908. https://doi.org/10.1093/schbul/sbp027
  35. Schultze-Lutter F, Wieneke A, Picker H, Rolff Y, Steinmeyer E, Ruhrmann S, et al. The schizophrenia prediction instrument, adult version (SPI-A). Schizophr Res 2004;70:76-77.
  36. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, et al. Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res 2008;105:10-17. https://doi.org/10.1016/j.schres.2008.07.012
  37. Ruhrmann S, Schultze-Lutter F, Salokangas RK, Heinimaa M, Linszen D, Dingemans P, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010;67:241-251. https://doi.org/10.1001/archgenpsychiatry.2009.206
  38. Yung AR, Killackey E, Hetrick SE, Parker AG, Schultze-Lutter F, Klosterkoetter J, et al. The prevention of schizophrenia. Int Rev Psychiatry 2007;19:633-646. https://doi.org/10.1080/09540260701797803
  39. Correll CU, Hauser M, Auther AM, Cornblatt BA. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry 2010;51:390-431. https://doi.org/10.1111/j.1469-7610.2010.02235.x
  40. Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 2006;32:166-178.
  41. Ruhrmann S, Schultze-Lutter F, Klosterk?tter J. Intervention in the at-risk state to prevent transition to psychosis. Curr Opin Psychiatry 2009;22:177-183. https://doi.org/10.1097/YCO.0b013e328324b687
  42. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 2004; 185:291-297. https://doi.org/10.1192/bjp.185.4.291
  43. Lee SY, Kim KR, Kang JI, Kim BR, Choi SH, Park JY. Grape cognitive therapy for isolation, wandering, confusion, misinterpretation, and unfamiliar voice.: expert manual. Seoul: Hakjisa;2011.
  44. Kim KR, Lee SY, Kang JI, Kim BR, Choi SH, Park JY, et al. Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultra-high risk for psychosis. Early Interv Psychiatry 2011;5:174-178. doi: 10.1111/j.1751-7893.2011.00267.x.
  45. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006;163:790-799. https://doi.org/10.1176/appi.ajp.163.5.790
  46. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010;67:146-154. https://doi.org/10.1001/archgenpsychiatry.2009.192
  47. Greene T. The Kraepelinian dichotomy: the twin pillars crumbling? Hist Psychiatry 2007;18:361-379. https://doi.org/10.1177/0957154X07078977
  48. Wyatt RJ, Alexander RC, Egan MF, Kirch DG. Schizophrenia, just the facts. What do we know, how well do we know it? Schizophr Res 1988;1:3-18. https://doi.org/10.1016/0920-9964(88)90034-5
  49. Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res 2009;110:1-23. https://doi.org/10.1016/j.schres.2009.03.005
  50. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 1970; 126:983-987.
  51. Haahr U, Friis S, Larsen TK, Melle I, Johannessen JO, Opjordsmoen S, et al. First-episode psychosis: diagnostic stability over one and two years. Psychopathology 2008;41:322-329. https://doi.org/10.1159/000146070
  52. Jakobsen KD, Frederiksen JN, Parnas J, Werge T. Diagnostic agreement of schizophrenia spectrum disorders among chronic patients with functional psychoses. Psychopathology 2006;39:269-276. https://doi.org/10.1159/000095731
  53. Ruhrmann S, Bechdolf A, Kühn KU, Wagner M, Schultze-Lutter F, Janssen B, et al. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry Suppl 2007;51:s88-s95.
  54. A decade for psychiatric disorders. Nature 2010;463:9. https://doi.org/10.1038/463009a